Rossmax International Ltd. (TPEX:4121)
15.10
-0.05 (-0.33%)
May 2, 2025, 1:30 PM CST
Rossmax International Revenue
In the year 2024, Rossmax International had annual revenue of 3.85B TWD with 1.11% growth. Rossmax International had revenue of 969.60M in the quarter ending December 31, 2024, with 0.98% growth.
Revenue
3.85B
Revenue Growth
+1.11%
P/S Ratio
0.34
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.85B | 42.10M | 1.11% |
Dec 31, 2023 | 3.81B | -535.69M | -12.33% |
Dec 31, 2022 | 4.34B | 397.05M | 10.06% |
Dec 31, 2021 | 3.95B | 268.93M | 7.31% |
Dec 31, 2020 | 3.68B | 585.02M | 18.91% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Polaris Group | 107.00M |
Pegavision | 6.82B |
Lumosa Therapeutics | 39.15M |